Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jesse Goodman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John M. Leonard - $1.44M in NTLA purchases and sales in the last 12 months
- Fred E. Cohen - $1.40M in NTLA purchases and sales in the last 12 months
- Edward J. Dulac III - $234K in NTLA purchases and sales in the last 12 months
- James Basta - $112K in NTLA purchases and sales in the last 12 months
- David Lebwohl - $110K in NTLA purchases and sales in the last 12 months
- Eliana Clark - $96K in NTLA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jesse Goodman?
Jesse Goodman is a corporate insider of Intellia Therapeutics, Inc. (NTLA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jesse Goodman last file a Form 4?
The most recent primary Form 4 on record is dated 10 June 2026, one of 2 filings going back to 2025.
Has Jesse Goodman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($29K) across all tracked filings.
